SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 167 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 21.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $104,000 | -17.5% | 80,948 | -18.4% | 0.00% | 0.0% |
Q4 2021 | $126,000 | -43.5% | 99,204 | -3.1% | 0.00% | 0.0% |
Q3 2021 | $223,000 | -41.2% | 102,407 | +1.3% | 0.00% | 0.0% |
Q2 2021 | $379,000 | +20.7% | 101,062 | +5.1% | 0.00% | 0.0% |
Q1 2021 | $314,000 | -5.4% | 96,195 | -1.1% | 0.00% | 0.0% |
Q4 2020 | $332,000 | -18.4% | 97,299 | -2.4% | 0.00% | -50.0% |
Q3 2020 | $407,000 | +48.0% | 99,710 | +22.4% | 0.00% | +100.0% |
Q2 2020 | $275,000 | +53.6% | 81,489 | +6.1% | 0.00% | 0.0% |
Q1 2020 | $179,000 | -39.1% | 76,828 | -4.7% | 0.00% | 0.0% |
Q4 2019 | $294,000 | -57.2% | 80,643 | -2.6% | 0.00% | -66.7% |
Q3 2019 | $687,000 | -3.9% | 82,814 | -0.2% | 0.00% | 0.0% |
Q2 2019 | $715,000 | -12.8% | 83,005 | +8.2% | 0.00% | 0.0% |
Q1 2019 | $820,000 | +19.5% | 76,733 | -2.1% | 0.00% | 0.0% |
Q4 2018 | $686,000 | -48.3% | 78,343 | -0.8% | 0.00% | -25.0% |
Q3 2018 | $1,326,000 | -16.4% | 78,939 | +4.3% | 0.00% | -33.3% |
Q2 2018 | $1,586,000 | +77.4% | 75,651 | +36.2% | 0.01% | +100.0% |
Q1 2018 | $894,000 | -32.2% | 55,545 | -20.1% | 0.00% | -25.0% |
Q4 2017 | $1,318,000 | +52.4% | 69,531 | +13.1% | 0.00% | +33.3% |
Q3 2017 | $865,000 | +102.1% | 61,452 | +7.0% | 0.00% | +50.0% |
Q2 2017 | $428,000 | +41.3% | 57,406 | +23.1% | 0.00% | +100.0% |
Q1 2017 | $303,000 | +38.4% | 46,648 | -5.8% | 0.00% | 0.0% |
Q4 2016 | $219,000 | -99.9% | 49,509 | -1.7% | 0.00% | 0.0% |
Q3 2016 | $235,158,000 | -26.6% | 50,355 | +3.3% | 0.00% | 0.0% |
Q2 2016 | $320,379,000 | +2.0% | 48,764 | -1.4% | 0.00% | 0.0% |
Q1 2016 | $314,000,000 | +9.0% | 49,466 | +3.4% | 0.00% | 0.0% |
Q4 2015 | $288,000,000 | +53134.8% | 47,836 | -47.1% | 0.00% | -50.0% |
Q3 2015 | $541,000 | -99.9% | 90,443 | +0.9% | 0.00% | 0.0% |
Q2 2015 | $612,994,000 | +104.4% | 89,619 | +81.4% | 0.00% | +100.0% |
Q1 2015 | $299,943,000 | -65.4% | 49,414 | -60.5% | 0.00% | -75.0% |
Q4 2014 | $867,643,000 | -12.2% | 125,201 | +3.1% | 0.00% | 0.0% |
Q3 2014 | $988,383,000 | +1.7% | 121,423 | +1.5% | 0.00% | 0.0% |
Q2 2014 | $972,209,000 | +155.2% | 119,583 | +146.1% | 0.00% | +100.0% |
Q1 2014 | $380,961,000 | -8.8% | 48,592 | +3.0% | 0.00% | 0.0% |
Q4 2013 | $417,632,000 | +11.1% | 47,190 | +5.4% | 0.00% | 0.0% |
Q3 2013 | $375,780,000 | +10.8% | 44,789 | -1.5% | 0.00% | 0.0% |
Q2 2013 | $339,184,000 | – | 45,467 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |